TNFRSF8 and mature T-cell and NK-cell non-Hodgkin lymphoma: CD30 expression levels for patients in ALCANZA (n = 50 MF patients who received BV), 35-IST-001 (n = 40 MF), 35-IST-002 (n = 32 MF), and SGN35-012 (n = 113 B cell NHL; n = 34 PTCL) are provided in Fig. 1.